NDC 63323-122 – Methotrexate
Methotrexate Sodium 1 g/1 · Injection, Powder, Lyophilized, For Solution · Intra-arterial, Intramuscular, Intrathecal, Intravenous
Product NDC63323-122
Product details
- Brand name
- Methotrexate
- Generic name
- Methotrexate Sodium
- Labeler
- Fresenius Kabi USA, LLC
- Dosage form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intra-arterial, Intramuscular, Intrathecal, Intravenous
- Marketing category
- ANDA · ANDA040266
- Marketed since
- January 22, 2000
- Listing expires
- December 31, 2026
- Pharmacologic class
- Folate Analog Metabolic Inhibitor
Active ingredients
- Methotrexate Sodium 1 g/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 63323-122-50 | 1 VIAL in 1 CARTON (63323-122-50) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL | Jan 22, 2000 |
Other Methotrexate products
- 50090-5457 Methotrexate Sodium 2.5 mg/1 · Tablet · A-S Medication Solutions
- 16729-486 Methotrexate Sodium 2.5 mg/1 · Tablet · Accord Healthcare Inc.
- 16729-277 Methotrexate 25 mg/mL · Injection · Accord Healthcare, Inc.
- 62332-711 Methotrexate Sodium 25 mg/mL · Injection, Solution · Alembic Pharmaceuticals Inc.
- 62332-712 Methotrexate Sodium 25 mg/mL · Injection, Solution · Alembic Pharmaceuticals Inc.
- 62332-730 Methotrexate Sodium 2.5 mg/1 · Tablet · Alembic Pharmaceuticals Inc.
- 46708-730 Methotrexate Sodium 2.5 mg/1 · Tablet · Alembic Pharmaceuticals Limited
- 46708-712 Methotrexate Sodium 25 mg/mL · Injection, Solution · Alembic Pharmaceuticals Limited
- 46708-711 Methotrexate Sodium 25 mg/mL · Injection, Solution · Alembic Pharmaceuticals Limited
- 59651-182 Methotrexate Sodium 2.5 mg/1 · Tablet · Aurobindo Pharma Limited
- 42291-594 Methotrexate Sodium 2.5 mg/1 · Tablet · AvKARE
- 50268-554 Methotrexate 2.5 mg/1 · Tablet · AvPAK